2009
DOI: 10.1152/ajpgi.00012.2009
|View full text |Cite
|
Sign up to set email alerts
|

Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis

Abstract: Clark JA, Gan H, Samocha AJ, Fox AC, Buchman TG, Coopersmith CM. Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 297: G471-G479, 2009. First published July 1, 2009 doi:10.1152/ajpgi.00012.2009.-Systemic administration of epidermal growth factor (EGF) decreases mortality in a murine model of septic peritonitis. Although EGF can have direct healing effects on the intestinal mucosa, it is unknown whethe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
57
2

Year Published

2010
2010
2017
2017

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 60 publications
(63 citation statements)
references
References 46 publications
4
57
2
Order By: Relevance
“…Systemic administration of EGF limits intestinal tissue damage, thereby reducing mortality in different animal models of noninfectious and infectious inflammation and intestinal injury. [30][31][32][33][34][35][36] In our study, pretreatment of MMP7 þ / þ mice with EGF reduced LPS-induced mortality ( Figure 3b) and LPS-induced intestinal permeability ( Figure 3c). Loss of gut barrier integrity can lead to efflux of bacterial gut flora or damage-associated molecular patterns, which can further activate inflammation by stimulation of PRRs in the submucosa, in the draining lymph nodes, or elsewhere.…”
Section: Mmp7 Is Expressed and Activated In The Paneth Cells Of The Isupporting
confidence: 59%
“…Systemic administration of EGF limits intestinal tissue damage, thereby reducing mortality in different animal models of noninfectious and infectious inflammation and intestinal injury. [30][31][32][33][34][35][36] In our study, pretreatment of MMP7 þ / þ mice with EGF reduced LPS-induced mortality ( Figure 3b) and LPS-induced intestinal permeability ( Figure 3c). Loss of gut barrier integrity can lead to efflux of bacterial gut flora or damage-associated molecular patterns, which can further activate inflammation by stimulation of PRRs in the submucosa, in the draining lymph nodes, or elsewhere.…”
Section: Mmp7 Is Expressed and Activated In The Paneth Cells Of The Isupporting
confidence: 59%
“…In vivo intestinal permeability was measured using the fluorescein isothiocyanate-labeled dextran (FD-4) method as described [27] with modification. Rats were administered 500 mL of FD-4 (300 mg/mL; SigmaeAldrich) by oral gavage at 18 h after CLP and sham.…”
Section: In Vivo Permeability Assaymentioning
confidence: 99%
“…decreased crypt proliferation (12)(13)(14)(15)(16)(17). Notably, sepsis induces intestinal hyperpermeability (18)(19)(20)(21).…”
mentioning
confidence: 99%